Achieve Life Sciences, Inc. Amortization
Achieve Life Sciences, Inc. (ACHV) reported Amortization of $223.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2022-03-10
- Achieve Life Sciences, Inc. amortization for fiscal 2021 was $223.00K, a 0.00% change from fiscal 2020.
- Achieve Life Sciences, Inc. amortization for fiscal 2020 was $223.00K, a 0.00% change from fiscal 2019.
- Achieve Life Sciences, Inc. amortization for fiscal 2019 was $223.00K, a 0.45% increase from fiscal 2018.
- Achieve Life Sciences, Inc. amortization for fiscal 2018 was $222.00K, a 0.45% decline from fiscal 2017.
| Period end | Amortization 12 month |
|---|---|
| 2021-12-31 | $223.00K 10-K · filed 2022-03-10 |
| 2020-12-31 | $223.00K 10-K · filed 2022-03-10 |
| 2019-12-31 | $223.00K 10-K · filed 2022-03-10 |
| 2018-12-31 | $222.00K 10-K · filed 2021-03-11 |
| 2017-12-31 | $223.00K 10-K · filed 2020-03-13 |
| 2016-12-31 | $223.00K 10-K · filed 2019-03-14 |
| 2015-12-31 | $140.00K 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |